Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
6.89
+0.41 (6.33%)
At close: Sep 4, 2026, 4:00 PM EDT
6.71
-0.18 (-2.61%)
After-hours: Sep 4, 2026, 7:47 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $3.41 billion as of September 4, 2026. Its market cap has decreased by -50.05% in one year.
Market Cap
3.41B
Enterprise Value
3.41B
1-Year Change
-50.05%
Ranking
Category
Stock Price
$6.89
ChartMarket Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $3.41B, an increase of 2,742.48%. That is a compound annual growth rate of 91.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 3.41B | -67.13% |
| Dec 31, 2025 | 10.38B | 16,053.85% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiniksa Pharmaceuticals International, | 6.08B |
| Amneal Pharmaceuticals | 6.07B |
| Amylyx Pharmaceuticals | 4.28B |
| Indivior Pharmaceuticals | 4.12B |
| BioCryst Pharmaceuticals | 2.55B |
| Supernus Pharmaceuticals | 2.53B |
| HUTCHMED (China) | 2.49B |
| Prestige Consumer Healthcare | 2.48B |